medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2019, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2019; 18 (1)


HLA Class II-DRB1 Alleles with Hepatitis C Virus Infection Outcome in Egypt: A Multicentre Family-based Study

El-Bendary M, Neamatallah M, Elalfy H, Besheer T, Kamel E, Mousa H, Eladl Abdel-Hamid, El-Setouhy M, El-Gilany Abdel-Hady, El-Waseef A, Esmat G

Idioma: Ingles.
Referencias bibliográficas: 51
Paginas: 68-77
Archivo PDF: 776.25 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes, E. Global Distribution and Prevalence of Hepatitis C Virus Genotypes. Hepatology (Baltimore, Md) 2015; 61: 77-87.

  2. El-Shabrawi MH, Kamal NM. Burden of pediatric hepatitis C. World J Gastroenterol 2013; 19: 7880-8.

  3. Yee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun 2004; 5: 237-45.

  4. El-Bendary M, Esmat G, Neamatallah M, Kamel E, Besheer T, Elalfy H, El-Setouhy M, et al. Epidemiological Aspects of Intrafamilial Spread of HCV Infection in Egyptian Population: A Pilot Study. Open J Gastroenterol 2014; 4: 228-36.

  5. Urabe Y, Ochi H, Kato N, Kumar V, Takahashi A, Muroyama R, Hosono N, et al. A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region. J Hepatol 2013; 58: 875-82.

  6. Kamal SM, Kassim SK, Ahmed AI, Mahmoud S, Bahnasy KA, Hafez TA, Aziz IA, et al. Host and Viral Determinants of the Outcome of Exposure to HCV Infection Genotype 4: A Large Longitudinal Study. Am J Gastroenterol 2014; 109: 199-211.

  7. Bruno R, Sacchi P, Maiocchi L, Zocchetti C, Filice G. Host factors affecting the outcome of treatment of hepatitis C. Rev Gastroenterol Disord 2004; 4(Suppl. 1): S3-7.

  8. Tripathy AS, Shankarkumar U, Chadha MS, Ghosh K, Arankalle VA. Association of HLA alleles with hepatitis C infection in Maharashtra, western India. Indian J Med Res 2009; 130: 550-5.

  9. El-Bendary M, Neamatallah M, Esmat G, Kamel E, Elalfy H, Besheer T, Eldeib D, et al. Associations of human leucocyte antigen class II-DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family-based study. Journal of Viral Hepatitis 2016; 23: 961-70.

  10. Shaker O, Bassiony H, El Raziky M, El-Kamary S, Esmat G, El- Ghor AM, Mohamed M. Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4. Mediat Inflamm 2013: 1-10.

  11. Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O’Brien SJ, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001; 184: 16-21.

  12. Perneger TV. What’s wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-8.

  13. Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, Puel J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113: 1675-81.

  14. Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, Bailly F, et al. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat 2007; 14: 460-7.

  15. Gad RR, Males S, El Makhzangy H, Shouman S, Hasan A, Attala M, El Hoseiny M, et al. Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C. Liver Int 2008; 28: 1112-9.

  16. Mahapatra C, Tripathy AS. Antigen Specific Cellular Response in Patients with Hepatitis C Virus Infection and its Association with HLA Alleles. IJCRIMPH 3.3 (2011): 273- 273.

  17. Lombard Z, Brune AE, Hoal EG, Babb C, Van Helden PD, Epplen JT, Bornman L. HLA class II disease associations in southern Africa. Tissue Antigens 2006; 67: 97-110.

  18. De Re V, Caggiari L, Monti G, Libra M, Spina M, Dolcetti R, De Zorzi M, et al. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin’s lymphoma is related to the type II mixed cryoglobulinemia. Tissue Antigens 2010; 75: 127-35.

  19. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13: 1770-87.

  20. Sim H, Wojcik J, Margulies M, Wade JA, Heathcote J. Response to interferon therapy: influence of human leucocyte antigen alleles in patients with chronic hepatitis C. J Viral Hepat 1998; 5: 249-53.

  21. Wang JH, Zheng X, Ke X, Dorak MT, Shen J, Boodram B, O’Gorman M, et al. Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol J 2009; 6: 46.

  22. Kuniholm MH, Kovacs A, Gao XJ, Xue XN, Marti D, Thio CL, Peters MG, et al. Specific Human Leukocyte Antigen Class I and II Alleles Associated with Hepatitis C Virus Viremia. Hepatology (Baltimore, Md) 2010; 51: 1514-22.

  23. McKiernan SM, Hagan R, Curry M, McDonald GS, Nolan N, Crowley J, Hegarty J, et al. The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology 2000; 118: 1124-30.

  24. Vejbaesya S, Songsivilai S, Tanwandee T, Rachaibun S, Chantangpol R, Dharakul T. HLA association with hepatitis C virus infection. Hum Immunol 2000; 61: 348-53.

  25. Hue S, Cacoub P, Renou C, Halfon P, Thibault V, Charlotte F, Picon M, et al. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis 2002; 186: 106-9.

  26. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, Walsh A, et al. Distinct MHC class I and II alleles are as sociated with hepatitis C viral clearance, originating from a single source. Hepatology (Baltimore, Md) 2004; 40: 108-14.

  27. Romero-Gomez M, Gonzalez-Escribano MF, Torres B, Barroso N, Montes-Cano MA, Sanchez-Munoz D, Nunez-Roldan A, et al. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C. Am J Gastroenterol 2003; 98: 1621-6.

  28. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JCE, James V, Trent Hepatitis C Virus Study Grp. Association between MHC class II alleles and clearance of circulating hepatitis C virus. J Infect Dis 1998; 178: 39-44.

  29. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC, Grp H. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 1999; 354: 2119-24.

  30. Lopez-Vazquez A, Rodrigo L, Mina-Blanco A, Martinez-Borra J, Fuentes D, Rodriguez M, Perez R, et al. Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 2004; 189: 957-63.

  31. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology (Baltimore, Md) 1998; 27: 240-4.

  32. Kallinowski B, Scherer S, Mehrabi A, Theilmann L, Stremmel W. Clinical impact of HLA DR B1 genotypes in chronic hepatitis C virus infection. Transplantation proceedings 1999; 31: 3346-49.

  33. Tillmann HL, Chen DF, Trautwein C, Kliem V, Grundey A, Berning-Haag A, Boker K, et al. Low frequency of HLADRB1* 11 in hepatitis C virus induced end stage liver disease. Gut 2001; 48: 714-8.

  34. Yenigun A, Durupinar B. Decreased frequency of the HLADRB1* 11 allele in patients with chronic hepatitis C virus infection. J Virol 2002; 76: 1787-9.

  35. Fanning LJ, Levis J, Kenny-Walsh E, Wynne F, Whelton M, Shanahan F. Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population. Hepatology (Baltimore, Md) 2000; 31: 1334-7.

  36. Alric L, Izopet J, Fort M, Vinel J-P, Fontenelle P, Orfila C, Payen J-L, et al. Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection. Hum Immunol 1999; 60: 516-23.

  37. Asti M, Martinetti M, Zavaglia C, Cuccia MC, Gusberti L, Tinelli C, Cividini A, et al. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology (Baltimore, Md) 1999; 29: 1272-9.

  38. Hong X, Yu R-B, Sun N-X, Wang B, Xu Y-C, Wu G-L. Human leukocyte antigen class II DQB1* 0301, DRB1* 1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J Gastroenterol 2005; 11: 7302-7.

  39. Corghi DB, Goncales NS, Marques SB, Goncales Jr FL. Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection. Braz J Med Biol Res 2008; 41: 884-9.

  40. Cangussu LOF, Teixeira R, Campos EF, Rampim GF, Mingoti SA, Martins OA, Gerbase-DeLima M. HLA Class II Alleles and Chronic Hepatitis C Virus Infection. Scand J Immunol 2011; 74: 282-7.

  41. Ali L, Mansoor A, Ahmad N, Siddiqi S, Mazhar K, Muazzam AG, Qamar R, et al. Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance. J Gen Virol 2010; 91: 1931-8.

  42. Samimi-Rad K, Sadeghi F, Amirzargar A, Eshraghian MR, Alavian SM, Rahimnia R. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran. J Med Virol 2015; 87: 1565-72.

  43. Hasan A-RS, Al-Ajeeli KSA. Association of Hepatitis C Virus (HCV) Infection and Human Leukocyte Antigens (HLA). Diyala Journal of Medicine 2: 53-9.

  44. Shaala A, Harfoush R, ElKhouly E, Ahmed M, Morsi M. Could Human Leukocyte Antigens (HLA) be Predictive Factors to Interferon Response among Chronic Hepatitis C Virus Hepatitis? J Med Microbiol Diagnos 2012; S1: 003. DOI:10.4172/ 2161-0703.S1-003

  45. Yosry A, Fouad R, Mahmoud S, El-Raziky MS, El-Hennawy A, Ghoneim MA. The association of HLA class II DR B1 alleles with HCV infection in Egyptian children. Arab J Gatroenterol 2011; 12: 25-8.

  46. Shankarkumar A, Shankarkumar U. HCV infection and its association with HLA alleles. International Journal of Life Sciences Biotechnology and Pharma Research 2012; 1: 10-9.

  47. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun, Y, et al. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis. Bmc Gastroenterol 2010; 10: 145-55.

  48. Romero V, Azocar J, Zúñiga J, Clavijo OP, Terreros D, Gu X, Husain Z, et al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Molecular Immunology 2008; 45: 2429-36.

  49. Wawrzynowicz-Syczewska M, Underhill JA, Clare MA, Boron- Kaczmarska A, McFarlane IG, Donaldson PT. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver 2000; 20: 234-9.

  50. Yoon SK, Han JY, Pyo CW, Yang JM, Jang JW, Kim CW, Im Chang U, et al. Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. Liver International 2005; 25: 1122-7.

  51. Ksiaa L, Ayed-Jendoubi S, Sfar I, Gorgi Y, Najjar HA, Abdallah TB, Ayed, K. Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. Viral Immunol 2007; 20: 312-9.




2020     |     www.medigraphic.com